| Year |
Citation |
Score |
| 2020 |
Scheggi S, Rossi F, Corsi S, Fanni S, Tronci E, Ludovica C, Vargiu R, Gambarana C, Muñoz A, Stancampiano R, Bjorklund A, Carta M. BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia. Journal of Parkinson's Disease. PMID 32651332 DOI: 10.3233/Jpd-202061 |
0.677 |
|
| 2020 |
Meloni M, Puligheddu M, Sanna F, Cannas A, Farris R, Tronci E, Figorilli M, Defazio G, Carta M. Efficacy and safety of 5-Hydroxytryptophan on levodopa-induced motor complications in Parkinson's disease: A preliminary finding. Journal of the Neurological Sciences. 415: 116869. PMID 32464351 DOI: 10.1016/J.Jns.2020.116869 |
0.606 |
|
| 2018 |
Fanni S, Scheggi S, Rossi F, Tronci E, Traccis F, Stancampiano R, De Montis MG, Devoto P, Gambarana C, Bortolato M, Frau R, Carta M. 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction. Neurobiology of Disease. 121: 120-130. PMID 30261284 DOI: 10.1016/J.Nbd.2018.09.018 |
0.711 |
|
| 2017 |
Tronci E, Francardo V. Animal models of L-DOPA-induced dyskinesia: the 6-OHDA-lesioned rat and mouse. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 29242978 DOI: 10.1007/S00702-017-1825-5 |
0.533 |
|
| 2017 |
Tronci E, Napolitano F, Muñoz A, Fidalgo C, Rossi F, Björklund A, Usiello A, Carta M. BDNF over-expression induces striatal serotonin fiber sprouting and increases the susceptibility to l-DOPA-induced dyskinesia in 6-OHDA-lesioned rats. Experimental Neurology. PMID 28757258 DOI: 10.1016/J.Expneurol.2017.07.017 |
0.683 |
|
| 2017 |
Frau R, Savoia P, Fanni S, Fiorentini C, Fidalgo C, Tronci E, Stancampiano R, Meloni M, Cannas A, Marrosu F, Bortolato M, Devoto P, Missale C, Carta M. The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease. Experimental Neurology. PMID 28131725 DOI: 10.1016/J.Expneurol.2017.01.012 |
0.701 |
|
| 2016 |
Pinna A, Ko WK, Costa G, Tronci E, Fidalgo C, Simola N, Li Q, Tabrizi MA, Bezard E, Carta M, Morelli M. Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26871939 DOI: 10.1002/Mds.26475 |
0.673 |
|
| 2016 |
Ghiglieri V, Mineo D, Vannelli A, Cacace F, Mancini M, Pendolino V, Napolitano F, di Maio A, Mellone M, Stanic J, Tronci E, Fidalgo C, Stancampiano R, Carta M, Calabresi P, et al. Modulation of serotonergic transmission by eltoprazine in L-DOPA-induced dyskinesia: Behavioral, molecular, and synaptic mechanisms. Neurobiology of Disease. 86: 140-53. PMID 26639853 DOI: 10.1016/J.Nbd.2015.11.022 |
0.71 |
|
| 2016 |
Fanni S, Frau R, Tronci E, Fidalgo C, Lisci C, Pardu A, Pes R, Saba P, Devoto P, Bortolato M, Carta M. P.2.018 Role of 5-alpha reductase in the pathophysiology of L-DOPA induced dyskinesia European Neuropsychopharmacology. 26: S38-S39. DOI: 10.1016/S0924-977X(16)70044-7 |
0.539 |
|
| 2015 |
Tronci E, Fidalgo C, Carta M. Foetal Cell Transplantation for Parkinson's Disease: Focus on Graft-Induced Dyskinesia. Parkinson's Disease. 2015: 563820. PMID 26881178 DOI: 10.1155/2015/563820 |
0.638 |
|
| 2015 |
Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, ... ... Tronci E, et al. Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease. Progress in Neurobiology. PMID 26209473 DOI: 10.1016/J.Pneurobio.2015.07.002 |
0.656 |
|
| 2015 |
Tronci E, Fidalgo C, Stancampiano R, Carta M. Effect of selective and non-selective serotonin receptor activation on l-DOPA-induced therapeutic efficacy and dyskinesia in parkinsonian rats. Behavioural Brain Research. 292: 300-304. PMID 26119238 DOI: 10.1016/J.Bbr.2015.06.034 |
0.717 |
|
| 2015 |
Fidalgo C, Ko WK, Tronci E, Li Q, Stancampiano R, Chuan Q, Bezard E, Carta M. Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease. Neuroscience. 298: 389-96. PMID 25907446 DOI: 10.1016/J.Neuroscience.2015.04.027 |
0.719 |
|
| 2015 |
Tronci E, Fidalgo C, Carta M. Foetal cell transplantation for Parkinson's disease: Focus on graft-induced dyskinesia Parkinson's Disease. 2015. DOI: 10.1155/2015/563820 |
0.499 |
|
| 2014 |
Carta M, Tronci E. Serotonin System Implication in l-DOPA-Induced Dyskinesia: From Animal Models to Clinical Investigations. Frontiers in Neurology. 5: 78. PMID 24904522 DOI: 10.3389/Fneur.2014.00078 |
0.667 |
|
| 2014 |
Tronci E, Fidalgo C, Zianni E, Collu M, Stancampiano R, Morelli M, Gardoni F, Carta M. Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease. Neuroscience. 265: 245-52. PMID 24486947 DOI: 10.1016/J.Neuroscience.2014.01.042 |
0.715 |
|
| 2014 |
Shin E, Lisci C, Tronci E, Fidalgo C, Stancampiano R, Björklund A, Carta M. The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation. Neurobiology of Disease. 62: 233-40. PMID 24135006 DOI: 10.1016/J.Nbd.2013.09.021 |
0.686 |
|
| 2014 |
Tronci E, Fidalgo C, Carta M. The serotonergic system in levodopa-induced dyskinesia Levodopa-Induced Dyskinesia in Parkinson's Disease. 199-212. DOI: 10.1007/978-1-4471-6503-3_11 |
0.579 |
|
| 2013 |
Bézard E, Muñoz A, Tronci E, Pioli EY, Li Q, Porras G, Björklund A, Carta M. Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia. Neuroscience Research. 77: 242-6. PMID 24135129 DOI: 10.1016/J.Neures.2013.10.002 |
0.738 |
|
| 2013 |
Tronci E, Lisci C, Stancampiano R, Fidalgo C, Collu M, Devoto P, Carta M. 5-Hydroxy-tryptophan for the treatment of L-DOPA-induced dyskinesia in the rat Parkinson's disease model. Neurobiology of Disease. 60: 108-14. PMID 24004632 DOI: 10.1016/J.Nbd.2013.08.014 |
0.732 |
|
| 2013 |
Bezard E, Tronci E, Pioli EY, Li Q, Porras G, Björklund A, Carta M. Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1088-96. PMID 23389842 DOI: 10.1002/Mds.25366 |
0.731 |
|
| 2013 |
Tronci E, Carta M. 5-HT1 receptor agonists for the treatment of L-DOPA-induced dyskinesia: From animal models to clinical investigation Basal Ganglia. 3: 9-13. DOI: 10.1016/J.Baga.2012.12.002 |
0.704 |
|
| 2012 |
Shin E, Tronci E, Carta M. Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease. Parkinson's Disease. 2012: 370190. PMID 22762012 DOI: 10.1155/2012/370190 |
0.719 |
|
| 2012 |
Tronci E, Shin E, Björklund A, Carta M. Amphetamine-induced rotation and L-DOPA-induced dyskinesia in the rat 6-OHDA model: a correlation study. Neuroscience Research. 73: 168-72. PMID 22450171 DOI: 10.1016/J.Neures.2012.03.004 |
0.652 |
|
| 2012 |
Simola N, Pinna A, Tronci E, Seeman P, Morelli M. Caffeine consumption and changes in the function of dopaminergic transmission: Evidence of a hyperdopaminergic state in rats subchronically treated with caffeine Caffeine Consumption and Health. 105-122. |
0.354 |
|
| 2010 |
Pinna A, Tronci E, Schintu N, Simola N, Volpini R, Pontis S, Cristalli G, Morelli M. A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug. Neuropharmacology. 58: 613-23. PMID 19951715 DOI: 10.1016/J.Neuropharm.2009.11.012 |
0.509 |
|
| 2009 |
Muñoz A, Carlsson T, Tronci E, Kirik D, Björklund A, Carta M. Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model. Experimental Neurology. 219: 298-307. PMID 19500572 DOI: 10.1016/J.Expneurol.2009.05.033 |
0.681 |
|
| 2008 |
Carta AR, Moreno CC, Cadoni C, Tronci E, Di Chiara G. Long-term increase in GAD67 mRNA expression in the central amygdala of rats sensitized by drugs and stress. The European Journal of Neuroscience. 27: 1220-30. PMID 18312583 DOI: 10.1111/J.1460-9568.2008.06095.X |
0.35 |
|
| 2007 |
Tronci E, Simola N, Borsini F, Schintu N, Frau L, Carminati P, Morelli M. Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats. European Journal of Pharmacology. 566: 94-102. PMID 17445798 DOI: 10.1016/J.Ejphar.2007.03.021 |
0.547 |
|
| 2006 |
Simola N, Tronci E, Pinna A, Morelli M. Subchronic-intermittent caffeine amplifies the motor effects of amphetamine in rats Amino Acids. 31: 359-363. PMID 16874467 DOI: 10.1007/S00726-006-0373-3 |
0.447 |
|
| 2006 |
Tronci E, Simola N, Carta AR, De Luca MA, Morelli M. Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons. Journal of Neurochemistry. 98: 1078-89. PMID 16771831 DOI: 10.1111/J.1471-4159.2006.03943.X |
0.482 |
|
| 2006 |
Carta M, Stancampiano R, Tronci E, Collu M, Usiello A, Morelli M, Fadda F. Vitamin A deficiency induces motor impairments and striatal cholinergic dysfunction in rats. Neuroscience. 139: 1163-72. PMID 16530976 DOI: 10.1016/J.Neuroscience.2006.01.027 |
0.606 |
|
| 2005 |
Carta AR, Tronci E, Pinna A, Morelli M. Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment European Journal of Neuroscience. 21: 1196-1204. PMID 15813929 DOI: 10.1111/J.1460-9568.2005.03944.X |
0.548 |
|
| 2005 |
Simola N, Tronci E, Cauli O, Carta A, De Luca M, Morelli M. A89 CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION WITH POST-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS Behavioural Pharmacology. 16: S51. DOI: 10.1097/00008877-200509001-00162 |
0.344 |
|
| 2003 |
Carta AR, Pinna A, Tronci E, Morelli M. Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats. Neurology. 61: S39-43. PMID 14663008 DOI: 10.1212/01.Wnl.0000095210.55600.9C |
0.576 |
|
| 2003 |
Carta AR, Fenu S, Pala P, Tronci E, Morelli M. Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats European Journal of Neuroscience. 18: 2563-2572. PMID 14622157 DOI: 10.1046/J.1460-9568.2003.02983.X |
0.492 |
|
| Show low-probability matches. |